
Amy Green
Freelance Health Writer, Journalist and Editor at Freelance
Health journalist & editor. Dancer. Rhodes. Tekano Fellow: https://t.co/9HgJ73sztS #EndTB #ODAAT M&G: https://t.co/PMbyBUrenF DM & Spotlight: https://t.co/xigf0HvRZE Insta: @amyzingreen
Articles
-
Aug 20, 2024 |
mdpi.com | Amy Green |Evangeline C Cowell |Laura Carr |Kim Hemsley
All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.
-
May 7, 2024 |
spotlightnsp.co.za | Amy Green |Biénne Huisman |Mandisa Dukashe |Luvuyo Mehlwana
A group of people discussing diabetes advocacy. (Photo: Sweet Life/Unsplash) Comment & Analysis7th May 2024 | Catherine Tomlinson Diabetes is the second leading cause of death in South Africa after tuberculosis, according to Statistics South Africa. It is the leading cause of death in women. Yet, despite being a major driver of deaths and illness, we do not have a clear picture of how many people in the country have diabetes or how many people are receiving diabetes care.
-
Feb 29, 2024 |
medium.com | Amy Green
It seems like a ‘trend’ at the moment, to announce to the world that we are taking a moment to rest. And I am all for it. Not the part about shouting it to the world — but to do it in the first place. And if we do have the call to share it, it can give others permission to rest themselves. This is the call I’ve been feeling the past week since moving home after travelling full time for the past 3 years.
-
Nov 3, 2023 |
spotlightnsp.co.za | Amy Green |Elna Schutz |Elna Schütz |Catherine Tomlinson
IMAGE: Nick Youngson CC BY-SA 3.0 Pix4free News & Features3rd November 2023 | Catherine Tomlinson Newly announced results of a pivotal phase 3 trial have demonstrated the effectiveness of a new one-dose treatment for gonorrhoea. The medicine, called zoliflodacin, is the first new drug developed to treat gonorrhoea in over 30 years. More than half of the 930 patients included in the trial were from South Africa, including women, adolescents, and people living with HIV.
-
Oct 9, 2023 |
spotlightnsp.co.za | Ufrieda Ho |Kathryn Cleary |Amy Green |Mark Heywood
Last month, she won the Mandela Rhodes Foundation’s award for social impact in Africa for a device that can help save the lives of women who suffer excessive bleeding after child birth. PHOTO: Nasief Manie/Spotlight News & Features9th October 2023 | Biénne Huisman As a child growing up in the Ugandan capital of Kampala, Maureen Etuket used a screwdriver to dismantle electronic appliances and toy trucks. “I was around eight, nine years old,” she says.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →Coverage map
X (formerly Twitter)
- Followers
- 1K
- Tweets
- 3K
- DMs Open
- No

RT @SpotlightNSP: IN CASE YOU MISSED IT: What you need to know about SA's rising #obesity levels & the meds that may help make a difference…

RT @SpotlightNSP: @AmyZinGreen asks where these new meds should fit into SA’s response to rising levels of #obesity. @HealthZA @FosterMohal…

RT @dailymaverick: Health Department deputy director-general Dr Nicholas Crisp has condemned the decision to host a vocal opponent of mRNA…